Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread
- Status
- RECRUITING
- Phase
- PHASE3
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE2
M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
- Status
- COMPLETED
- Phase
- PHASE2
Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and Carboplatin
- Status
- WITHDRAWN
- Phase
- PHASE1
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- Status
- RECRUITING
- Phase
- PHASE2
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.
- Status
- UNKNOWN
- Phase
- PHASE2
Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2